COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement

01/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 1 June 2018 Shire [...]

DBV Technologies: Ordinary and Extraordinary General Meeting of June 22, 2018 - Procedures for Obtaining Preparatory Documents for the General Meeting

01/06/2018 - 07:31

Montrouge, France, June 1, 2018 Ordinary and Extraordinary General Meeting of June 22, 2018 Procedures for Obtaining Preparatory Documents for the General Meeting DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - [...]

DBV Technologies : Assemblée Générale Mixte du 22 juin 2018 - Modalités de mise à disposition des documents préparatoires à l'Assemblée

01/06/2018 - 07:31

Montrouge, France, le 1 juin (07h30 CEST) 2018 Assemblée Générale Mixte du 22 juin 2018 Modalités de mise à disposition des documents préparatoires à l'Assemblée DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - [...]

Vericel Corporation Prices $65 Million Public Offering of Common Stock

01/06/2018 - 02:14

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the pricing of its [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/06/2018 - 00:00

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]

Mount Tam Biotechnologies Announces Stockholder Approvals

31/05/2018 - 23:17

NOVATO, CA, May 31, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam" or the “Company”) (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to [...]

Wave Life Sciences to Present at the Jefferies 2018 Healthcare Conference

31/05/2018 - 23:11

CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, [...]

Menlo Therapeutics to Present at Upcoming Investor Conferences

31/05/2018 - 23:00

REDWOOD CITY, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]

Intuitive Surgical Announces Innovative Single Port Platform — the da Vinci SP® Surgical System

31/05/2018 - 22:59

Allows for narrow access surgery using a single port SUNNYVALE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), today announced a new U.S. Food and Drug Administration (FDA) clearance [...]

Tonix Pharmaceuticals Presented New Data Related to Suicidal Ideation and Behaviors in Military-Related PTSD from the Phase 2 AtEase Study at the American Society of Clinical Psychopharmacology

31/05/2018 - 22:30

Clinical Benefit of Tonmya, an FDA-Designated Breakthrough Therapy for PTSD, was Evidenced in AtEase NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), presented data [...]

Oncolytics Biotech® Announces Public Offering of Common Shares

31/05/2018 - 22:27

CALGARY, Alberta and SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (OTCQX:ONCYD), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus turning [...]

Reata Announces Orphan Drug Designation From the European Commission for Bardoxolone Methyl for the Treatment of Alport Syndrome

31/05/2018 - 22:15

IRVING, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that the European Commission (EC) has granted orphan drug [...]

Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH

31/05/2018 - 22:15

CHARLESTON, S.C., May 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna [...]

TRACON Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference

31/05/2018 - 22:10

SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and [...]

TRACON Pharmaceuticals Reports Granting of Inducement Award

31/05/2018 - 22:05

SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a biopharmaceutical company that develops targeted therapies for cancer and wet age-related macular degeneration, announced today that it [...]

Myriad Genetics to Present at Two Upcoming Investor Conferences

31/05/2018 - 22:05

SALT LAKE CITY, May 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced that it will be presenting at two upcoming investor [...]

Fibrocell Announces Closing of $6.0 Million Registered Direct Offering

31/05/2018 - 22:05

EXTON, Pa., May 31, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

Neos Therapeutics to Participate in Two June Conferences

31/05/2018 - 22:05

DALLAS and FORT WORTH, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]

Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019

31/05/2018 - 22:05

- Lead Investigational New Drug (“IND”) program for Alpha-1-antitrypsin deficiency (“A1AT”) received FDA’s orphan drug designation and is on track for commencing IND-enabling studies in fiscal 2019 - Second IND-track [...]